Trans-auricular Vagal Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Sickle Cell Disease
Interventions
DEVICE

taVNS device

"Sparrow Link taVNS device from Spark Biomedical, a non-invasive, adhesive earpiece placed on the tragus of the ear to deliver vagal nerve stimulation. The stimulation level is titrated by the investigator to a perceptible but comfortable intensity. Patients cannot adjust the settings themselves, though adjustments can be made upon request.~The device consists of a disposable earpiece connected by a cable to a battery-powered controller (3 AAA batteries). It emits a biphasic, rectangular waveform with a 100 µs interphase and a maximum output of 95V."

Trial Locations (1)

30329

RECRUITING

Children's Hospital of Atlanta: Eagelston, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT07090668 - Trans-auricular Vagal Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease | Biotech Hunter | Biotech Hunter